Hyper Screening X

Hyper Screening X utilizes RxnFlow to efficiently explore a 7-trillion-compound ultra-large library, identifying innovative drug candidates with low binding energy and over 85% synthetic feasibility.

References

2025

  1. ICLR
    Generative Flows on Synthetic Pathway for Drug Design
    Seonghwan Seo, Minsu Kim, Tony Shen, Martin Ester, Jinkyoo Park, Sungsoo Ahn, and Woo Youn Kim
    In The Thirteenth International Conference on Learning Representations, 2025
    * Previously presented at NeurIPS AIDrugX Workshop 2024
    arXiv Blog Code